Independent research tool — not a government agency. Official notices govern.Refreshed
ClosedOpportunity 720FDA18RFI01

Input into USAID/OFDA’s Infectious Disease (with Epidemic or Pandemic potential) Standby Capacity for Humanitarian Emergency Annual Program Statement (APS)

Agency for International Development

At a glance

Input into USAID/OFDA’s Infectious Disease (with Epidemic or Pandemic potential) Standby Capacity for Humanitarian Emergency Annual Program Statement (APS) is a closed federal other opportunity from the Agency for International Development. The application deadline was November 21, 2017. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 98.001 (USAID Foreign Assistance for Programs Overseas).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

  1. Nov 15, 2017Posted
  2. Nov 21, 2017Application deadline
Posted
Nov 15, 2017
Close date
Nov 21, 2017
Award floor
Not specified
Award ceiling
Not specified
Est. total funding
Not specified
Expected awards
Not specified
Cost sharing
Not required
Funding instrument
Other
Opportunity category
Discretionary

Who can apply

  • Unrestricted (any entity type)

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

The U.S. Agency for International Development (USAID) through the Office for Foreign Disaster Assistance (OFDA), is publishing the subject Request for Information (RFI) in order to obtain information and input from all interested public and private parties on Infectious Disease (with Epidemic or Pandemic potential) Standby and Augment Capacity for a Humanitarian Emergency. At this time, USAID is seeking responses to the questions of this RFI as detailed below. Please note this is not a call for concept notes or applications. Responses to this RFI do not constitute a binding agreement or commitment by the U.S. Government to issue any awards, or pay for any information submitted as a result of this request. Any applications submitted in response to this request will not be considered. If a future Request for Applications (RFA) or Annual Program Statement (APS) is issued, it will be announced on Grants.gov website at www.grants.gov at a later date. Responses to each question are optional and a respondent may select to which questions it chooses to respond. Responses must be succinct, specific, clear, and written in English. Responses to specific questions should be directly related to that particular query. General feedback may be provided at the end of the response. Respondents can only submit ONE response per individual or organization. All responses should be sent to IDAPOFDA@ofda.gov. Further information is included in the full RFI attached.

Assistance Listing

What is an ALN?

Reported obligations under ALN 98.001

Historical data · not a prediction
FY19$10.3B
FY20$10.3B est.
FY21$10.3B est.
FY22$28.8B
FY23$30B est.
FY24$32B est.
Source: SAM.gov Assistance Listing 98.001. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

IDAPOFDA@ofda.gov

Quick answers

Who is eligible to apply for this opportunity?

The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.

How do I apply for this opportunity?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity 720FDA18RFI01), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.